Lifecore Biomedical (NASDAQ: LFCR) reported Q3 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $31.11 million versus the consensus estimate of $26.35 million.

GUIDANCE:

Lifecore Biomedical sees FY2025 revenue of $74-76 million, versus the consensus of $131.9 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.